Literature DB >> 19166661

Hepatic assist devices: will they ever be successful?

Norman L Sussman1, Brendan M McGuire, James H Kelly.   

Abstract

Hepatic assist remains elusive. Bioartificial livers (BALs), consisting of liver cells or tissue in a synthetic housing, have been promising but have not proven successful in clinical trials. Artificial livers that consist of sophisticated sorbents and membranes cannot support a failing liver but may shorten episodes of acute decompensation in patients with stable cirrhosis. These artificial livers are most likely to find a place as temporary support prior to transplantation. True liver support will require a BAL. This article proposes goals for making a clinically useful BAL, with attention to systems biology and potential sources of hepatocytes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19166661     DOI: 10.1007/s11894-009-0010-x

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  32 in total

1.  Acetaminophen toxicity: changing perceptions on a social/medical issue.

Authors:  William M Lee
Journal:  Hepatology       Date:  2007-10       Impact factor: 17.425

Review 2.  Extracorporeal liver support: cell-based therapy for the failing liver.

Authors:  N L Sussman; J H Kelly
Journal:  Am J Kidney Dis       Date:  1997-11       Impact factor: 8.860

3.  Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure.

Authors:  A J Ellis; R D Hughes; J A Wendon; J Dunne; P G Langley; J H Kelly; G T Gislason; N L Sussman; R Williams
Journal:  Hepatology       Date:  1996-12       Impact factor: 17.425

Review 4.  A bioartificial liver--state of the art.

Authors:  Alastair J Strain; James M Neuberger
Journal:  Science       Date:  2002-02-08       Impact factor: 47.728

Review 5.  Artificial and bioartificial liver support.

Authors:  Travis J McKenzie; Joseph B Lillegard; Scott L Nyberg
Journal:  Semin Liver Dis       Date:  2008-05       Impact factor: 6.115

Review 6.  Artificial liver support systems in the management of complications of cirrhosis.

Authors:  Vanessa Stadlbauer; Nathan A Davies; Sambit Sen; Rajiv Jalan
Journal:  Semin Liver Dis       Date:  2008-02       Impact factor: 6.115

7.  Evaluation of a new immortalized human fetal liver cell line (cBAL111) for application in bioartificial liver.

Authors:  Paul P C Poyck; Albert C W A van Wijk; Tessa V van der Hoeven; Dirk R de Waart; Robert A F M Chamuleau; Thomas M van Gulik; Ronald P J Oude Elferink; Ruurdtje Hoekstra
Journal:  J Hepatol       Date:  2007-12-17       Impact factor: 25.083

8.  Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure.

Authors:  J G O'Grady; A E Gimson; C J O'Brien; A Pucknell; R D Hughes; R Williams
Journal:  Gastroenterology       Date:  1988-05       Impact factor: 22.682

9.  Homogeneous differentiation of hepatocyte-like cells from embryonic stem cells: applications for the treatment of liver failure.

Authors:  Cheul H Cho; Natesh Parashurama; Eric Y H Park; Kazuhiro Suganuma; Yaakov Nahmias; Jaesung Park; Arno W Tilles; François Berthiaume; Martin L Yarmush
Journal:  FASEB J       Date:  2007-10-17       Impact factor: 5.191

10.  Human hepatic stem cells from fetal and postnatal donors.

Authors:  Eva Schmelzer; Lili Zhang; Andrew Bruce; Eliane Wauthier; John Ludlow; Hsin-lei Yao; Nicholas Moss; Alaa Melhem; Randall McClelland; William Turner; Michael Kulik; Sonya Sherwood; Tommi Tallheden; Nancy Cheng; Mark E Furth; Lola M Reid
Journal:  J Exp Med       Date:  2007-07-30       Impact factor: 14.307

View more
  3 in total

Review 1.  Cell therapies for liver diseases.

Authors:  Yue Yu; James E Fisher; Joseph B Lillegard; Brian Rodysill; Bruce Amiot; Scott L Nyberg
Journal:  Liver Transpl       Date:  2012-01       Impact factor: 5.799

2.  Optimization of mass transfer for toxin removal and immunoprotection of hepatocytes in a bioartificial liver.

Authors:  Geir I Nedredal; Bruce P Amiot; Peter Nyberg; Jennifer Luebke-Wheeler; Joseph B Lillegard; Travis J McKenzie; Scott L Nyberg
Journal:  Biotechnol Bioeng       Date:  2009-12-01       Impact factor: 4.530

3.  Experimental bio-artificial liver: Importance of the architectural design on ammonia detoxification performance.

Authors:  María Dolores Pizarro; María Eugenia Mamprin; Lucas Damián Daurelio; Joaquín Valentín Rodriguez; María Gabriela Mediavilla
Journal:  World J Hepatol       Date:  2018-10-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.